In 2024, the Brazilian National Health Surveillance Agency (Anvisa) – an agency linked to the Ministry of Health that coordinates the National Health Surveillance System (SNVS) – celebrated its 25th anniversary.
Through the regulation and oversight of matters related to health surveillance, Anvisa has enabled the introduction of measures, standards, and principles aimed at effectively protecting public health since its establishment in the late 20th century.
Since then, Anvisa's actions, as well as those of other agencies responsible for regulating and overseeing health and population well-being – such as the Brazilian National Supplementary Health Agency (ANS) and the Ministry of Agriculture, Livestock and Food Supply (Mapa) – have been essential for strengthening the quality, safety, and efficacy of products and services available to the Brazilian population.
The year of 2024 was marked by significant developments in the legal and regulatory realms regarding important issues for regulated sectors in areas such as food, cosmetics, medical devices, agricultural inputs, pharmaceuticals, health plans, etc., in addition to procedural issues inherent to the authorities' activities and prerogatives related to health surveillance.
This e-book was prepared by the Life Sciences & Healthcare practice of TozziniFreire Advogados to provide insights into what to expect for 2025, as well as considerations related to the most important topics discussed in 2024 within the main agencies of the sector.
The text you will read below is based on a compilation of newsletters published by our team in 2024, with relevant additions to help you navigate the regulatory environment in 2025.
To check out the full content, please click here.